Cargando…

Adjuvant Rituximab—Exploratory Trial in Young People With Graves Disease

CONTEXT: Remission rates in young people with Graves hyperthyroidism are less than 25% after 2 years of thionamide antithyroid drug (ATD). OBJECTIVE: We explored whether rituximab (RTX), a B-lymphocyte–depleting agent, would increase remission rates when administered with a short course of ATD. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheetham, Tim D, Cole, Michael, Abinun, Mario, Allahabadia, Amit, Barratt, Tim, Davies, Justin H, Dimitri, Paul, Drake, Amanda, Mohamed, Zainaba, Murray, Robert D, Steele, Caroline A, Zammitt, Nicola, Carnell, Sonya, Prichard, Jonathan, Watson, Gillian, Hambleton, Sophie, Matthews, John N S, Pearce, Simon H S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851941/ https://www.ncbi.nlm.nih.gov/pubmed/34687316 http://dx.doi.org/10.1210/clinem/dgab763

Ejemplares similares

Adjuvant rituximab, a potential treatment for the young patient with Graves’ hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial
por: Cole, Michael, et al.
Publicado: (2019)

New Therapeutic Horizons for Graves’ Hyperthyroidism
por: Lane, Laura C, et al.
Publicado: (2020)

Rituximab: a novel treatment for refractory Riedel’s thyroiditis
por: Hunt, Leanne, et al.
Publicado: (2018)

Graves’ disease: moving forwards
por: Lane, Laura C, et al.
Publicado: (2023)

Epidemiology, management and outcomes of Graves’ disease—real life data
por: Hussain, Y. S., et al.
Publicado: (2017)

Rituximab in the treatment of Graves’ orbitopathy: latest updates and perspectives
por: Supronik, Jakub, et al.
Publicado: (2022)

2022 European Thyroid Association Guideline for the management of pediatric Graves’ disease
por: Mooij, Christiaan F, et al.
Publicado: (2021)

Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy
por: Pandit, Aditi, et al.
Publicado: (2013)

Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis
por: Şimşek, Tülay, et al.
Publicado: (2017)

Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy
por: de Keizer, Bart, et al.
Publicado: (2019)

Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy
por: Campi, Irene, et al.
Publicado: (2022)

Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study
por: Wheater, Gillian, et al.
Publicado: (2018)

Use of Rituximab After Orbital Decompression Surgery in Two Grave’s Ophthalmopathy Patients Progressing to Optic Neuropathy
por: Zhang, Benping, et al.
Publicado: (2020)

An Intronic HCP5 Variant Is Associated With Age of Onset and Susceptibility to Graves Disease in UK and Polish Cohorts
por: Lane, Laura Claire, et al.
Publicado: (2020)

Advances in Graves' Disease
por: Galofré, Juan C., et al.
Publicado: (2012)

Utility of rituximab treatment for exophthalmos, myxedema, and osteoarthropathy syndrome resistant to corticosteroids due to Graves’ disease: a case report
por: Ferreira-Hermosillo, Aldo, et al.
Publicado: (2018)

6-hydroxydopamine-mediated release of norepinephrine increases faecal excretion of Salmonella enterica serovar Typhimurium in pigs
por: Pullinger, Gillian D., et al.
Publicado: (2010)

How to use thionamide anti-thyroid drug in the young– what’s new?
por: Cheetham, Tim
Publicado: (2021)

Increasing Incidence, but Lack of Seasonality, of Elevated TSH Levels, on Newborn Screening, in the North of England
por: Pearce, Mark S., et al.
Publicado: (2010)

Time Savings with Rituximab Subcutaneous Injection versus Rituximab Intravenous Infusion: A Time and Motion Study in Eight Countries
por: De Cock, Erwin, et al.
Publicado: (2016)

Graves of Graves' Disease, 1796—1853
por: Taylor, Selwyn
Publicado: (1986)

Attitudes About Informed Consent: An Exploratory Qualitative Analysis of UK Psychotherapy Trainees
por: Blease, Charlotte R., et al.
Publicado: (2020)

The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy
por: Hou, Jueyu, et al.
Publicado: (2021)

Unilateral Graves' Disease
por: Mahalakshmi, VNSSVAMS D, et al.
Publicado: (2019)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

Muscle Function, Body Composition, Insulin Sensitivity and Physical Activity in Adolescents Born Preterm: Impact of Gestation and Vitamin D Status
por: Wood, Claire L., et al.
Publicado: (2022)

Hyperinsulinaemic Hypoglycaemia: Genetic Mechanisms, Diagnosis and Management
por: Mohamed, Zainaba, et al.
Publicado: (2012)

Rituximab
por: Tridente, Giuseppe
Publicado: (2013)

The Influence of Juvenile Graves' Ophthalmopathy on Graves' Disease Course
por: Jankauskiene, Jurate, et al.
Publicado: (2017)

Graves’ disease and Graves’ orbitopathy following COVID-19
por: Lanzolla, G., et al.
Publicado: (2021)

Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
por: Lanzolla, G., et al.
Publicado: (2022)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Outcome of Hematopoietic Stem Cell Transplantation in patients with Mendelian Susceptibility to Mycobacterial Diseases
por: Radwan, Nesrine, et al.
Publicado: (2021)

Plegaria grave
por: Pasamanik, Luisa
Publicado: (1958)

Neumonías graves
Publicado: (1996)

Graves' Orbitopathy
por: Hiromatsu, Yuji, et al.
Publicado: (2015)

Graves' Disease
Publicado: (1895)

Grave Robbing
Publicado: (1883)

The Grave of Hope
Publicado: (1859)

The Grave of Hope
Publicado: (1882)

Cannot write session to /tmp/vufind_sessions/sess_rg87t9ak5ti394fritt5cn8uim